
3Biotech
3biotech is a company specialized in CMC and pharmaceutical development. We support our customers from the research phase to the first human injection and commercialization.
CMC
Bioproduction
Biomanufacturing
Drug Development
• We define, in agreement with our client, the drug development strategy (Target Product Profile, development plan, preclinical studies ...),
• We offer the most appropriate technological solutions (cell lines, manufacturing processes, analytical methods, ...),
• We select, worldwide, the most appropriate CRO / CDMOs for the project,
• We lead and coordinate all stakeholders and ensure timelines, quality and cost
• We program and monitor the production of clinical batches,
• We help with the writing of IMPD and IND, ....
- antibodies
- cellular immunotherapy
- cardiology
- genetic diseases
- hematology
- infectiology
- immunology
- oncology
- ophtalmology
Expertise
- Manufacturability
- Production quality
- CMC feasibility
- Indication Prioritization
- Antibody humanization
- Proof of concept
- Pharmacology potency
- Exploratory toxicology
- in-vitro & ex-vivo models
- in-vivo models
- GLP compliance
- GMP compliance
- Master Cell Bank
- Production
- Cell Line development
- Clone selection
- Characterization
- Storage
- Analytical development
- Cell Culture
- Media composition
- Bioreactor conditions
- Gene modification / Transduction
- Retroviral & lentiviral vectors
- Cell expansion
- Wave-mixed bioreactors
- Stirred tank reactors
- Batches production type
- Mammalian
- Insect
- Bacterial
- GLP compliance
- GMP compliance
- Pilot Batches
- Tests
- Optimization
- Scale-Up process
- Process optimization & validation
- Volume
- Preclinical / Tox
- Low volume (< 200 L)
- High volume (200 – 2000 L)
- Very high volume (> 2000 L)
- Commercial
- USP (Scale-Up)
- Cell expansion
- Inoculation
- Low volume containers to Bioreactors
- DSP (Recovery)
- Harvest
- Filtration
- Purification
- Fill & Finish
- Aseptic filling
- Lyophilization
- Batch release
- Storage matter
- Instruction
- Logistic
- Cell cryopreservation
- thaw
- Stability Assessment
- Physical & chemical profile
- Shear/shaking
- Viscosity
- Photostability
- pH
- Freeze/thaw
- Heat/degradation
- Aggregation
- Cell line analytical development
- Host cell proteins
- Viral clearance
- Contaminants detection
- Biosafety & Bioanalysis
- Toxicology
- PK/PD features
- Impurities detection
- Bioproduction analytical test
- Monitoring
- Characterization
- Batch consistency
- Batch release test
- Chemical, physical, biological test
- Quality control test support
- Post-production test
- Real-time stability test
- Formulation
- Dose
- Stability
- Excipients
- Adjuvants
- Sterilization
- Lyophilization
- Storage stability
- Delivery
- Route of Administration
- Phase I
- Phase II
- Phase III
- Regulatory Filing
Category
- Service
Contact
- Olivier Favre-Bulle
CEO - 66 Avenue des Champs Elysées 75008 Paris
- 0176504045
- contact@3Biotech.com
- https://www.3biotech.com/